Is LINC worth buying
Is it worth buying
Data confidence: high (3/3)
61×0.4 + 30×0.35 + 59×0.25
LINC's strength is in the company's own numbers: revenue grew 22% versus the same quarter a year ago, the 10th consecutive growing quarter, and also in delivery against expectations: in the last four reports the company beat the earnings estimate 3 times and the revenue estimate 4 times.
The weakness is in the technical picture: of 13 technical measures checked, 1 point up and 9 point down, and also in the company's own numbers: free cash flow of -$9M over the past year — -2% of revenue.
In the background, last quarter 5 of the large holders added and 3 trimmed, and 2 opened a new position, and over the past three months the stock lagged the index by 20.0 percentage points.
So although the business itself holds up, there is no technical entry point right now — it opens on a close above $38.34.
This read has held for 1 days.
Computed analysis from public data — not investment advice or a recommendation.
Forward earnings estimates are being revised up.
Weaker than the market — lagging the index.-20pp
Market backdrop: Positive market (Risk-On).
Financial health
Leaning positive
61/1003 of 8 checks are positive, 1 negative.
Revenue grew 22% versus the same quarter a year ago, the 10th consecutive growing quarter. The growth rate is steady. Earnings per share rose 20% year over year, a 3-quarter streak. Free cash flow of -$9M over the past year — -2% of revenue. The company spends more cash than it takes in.
All the numbers in ProTechnical analysis
Weak
30/1000 of 7 checks are positive, 3 negative.
Of 13 technical measures checked, 1 point up and 9 point down. Price is 12.8% below the 200-day average. Below the long average, the long-term trend is still down. The relative strength index reads 25. Below 30 is considered oversold.
All the numbers in ProMarket psychology
Leaning positive
59/1005 of 9 checks are positive, 3 negative. (1 checks have no data.)
Last quarter 5 of the large holders added and 3 trimmed, and 2 opened a new position. Over the past three months the stock lagged the index by 20.0 percentage points. Alyeska Investment Group, L.p. cut its position by 52%.
All the numbers in ProThe company's future
Leaning positive
61/1001 of 5 checks are positive, 0 negative.
In the last four reports the company beat the earnings estimate 3 times and the revenue estimate 4 times. The outlook management itself gave in the 2026-08-10 release: The company's forecast about itself — not the market's, and not a promise. The money the company spends is going into a mix of investment and running cost.
All the numbers in ProThese are measured facts — not a recommendation, not a forecast, not a promise.
These are market expectations about the future — not facts or a promise, and they change often.
Next-year earnings estimates moved +2% over the last 3 months.
The market is getting more optimistic.
~25% growth expected next year · מכפיל רווח עתידי 30.
Most of the future is priced — less room for error.
The price is 86% below the average analyst target.
There is room above according to those covering it — but targets move and often don't come true.
At the current burn, cash lasts ~19 quarters.
No near-term raise pressure.
Entry strategy · LINC
PRO$20/month after the trial · cancel anytime
Bottom line: the company's numbers — leaning positive; the technical picture — weak; and how the market behaves around it — leaning positive. The single largest risk here is that of 13 technical measures checked, 1 point up and 9 point down. What would change the read: A close above $38.34.
All data, scores and signals on this page are produced by an automated system and based on technical and quantitative data only. They are not investment advice, investment marketing or a recommendation to act, and are not a substitute for personal advice from a licensed professional. Trading securities involves substantial risk, up to the full loss of your investment; every decision is your sole responsibility.